Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tryptophan 5-hydroxylase 1 (TPH1) is an isoenzyme of tryptophan hydroxylase, encoded by the *TPH1* gene. It catalyzes the rate-limiting step in serotonin biosynthesis by converting L-tryptophan to 5-hydroxy-L-tryptophan (5-HTP), which is then decarboxylated to form serotonin. TPH1 is primarily expressed in peripheral tissues. It plays key roles as a neurotransmitter/hormone involved in gut motility, vascular tone regulation, platelet aggregation, and immune modulation. Recent research highlights immunoregulatory functions and suggests that tryptophan depletion itself has immunomodulatory consequences. Pharmacological inhibition of tryptophan hydroxylases can reduce peripheral serotonin synthesis; conversely, increased substrate availability may have antidepressant effects.
Inhibition of tryptophan hydroxylase to reduce peripheral serotonin synthesis; Modulation of serotonin production through substrate availability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tryptophan 5-hydroxylase 1 (TPH1).